Lymphoma in cats: treatment, prognosis and clinical trials

Confirm that the diagnosis really fits low-grade intestinal lymphoma and discuss whether oral therapy is appropriate. Track weight, appetite, vomiting or diarrhea, and laboratory changes rather than judging response only by whether a mass is visible.

This usually needs a more urgent systemic-treatment discussion than low-grade intestinal disease. Sampling, subtype, and the cat’s clinical condition determine how quickly treatment should start.

Keep exact drug names, doses, and dates. Do not stop steroids abruptly without instructions. Prior treatment and the quality and duration of response matter if lymphoma progresses or a trial is considered.

• What anatomic form and grade of lymphoma does my cat have?
• Do we need biopsy, immunophenotyping or another test before treatment?
• Is this a form where oral therapy is reasonable, or is multi-agent chemotherapy or radiation more appropriate?

The useful record identifies the anatomic form—such as intestinal, nasal, mediastinal, renal, or multicentric—and low- or high-grade behavior when possible. Cell lineage can matter in selected cases. Biopsy, cytology, flow cytometry, PARR, and immunohistochemistry answer different questions; not every cat needs every test.

Track appetite, weight, vomiting or diarrhea, breathing, nasal airflow, drinking and urination, and any enlarged nodes according to the lymphoma site. Marked weakness, repeated vomiting, breathing difficulty, inability to eat, or rapid decline should not wait. Remission is control of detectable disease, not the same as cure.

Treatment depends on the form and grade of lymphoma. Some low-grade intestinal lymphomas can be controlled with oral chemotherapy and a corticosteroid, while high-grade disease usually needs more intensive multi-agent chemotherapy. Radiation is especially useful for selected localized forms such as nasal lymphoma.

Where the lymphoma is, whether it is low-grade or high-grade, how certain the diagnosis is, prior steroid or chemotherapy exposure and overall health are the main treatment-changing factors.

The most useful tests establish the anatomic form and grade. Cytology or biopsy may be enough in some cases, while flow cytometry, PARR or immunohistochemistry can help when the diagnosis is uncertain. CBC, chemistry and site-appropriate staging are commonly useful before treatment.